Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings
Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings
复制标题
DOI：
10.1016/j.nedt.2012.04.022
复制
发表时间：
2013-05-01
影响因子：
3.9
通讯作者：
Tait, Fiona
中科院分区：
文献类型：
--
作者：
Chenoweth, Lynn;Sheriff, June;Tait, Fiona
目的：为了确定帕金森病医学教育计划对护理人员的知识和实践的影响，帕金森病患者在两种环境中接受护理：医院和老年护理机构。帕金森氏病药物治疗方案计划旨在增加护理管理中的帕金森氏病药物管理和安全性的护士知识，以改善帕金森氏病患者的健康状况，功能和福祉。背景：发达国家的人口老龄化伴随着慢性疾病的增加，帕金森氏病是最衰弱和昂贵的疾病之一。个别复杂的药物治疗方案和独特的症状谱需要护士的疾病特异性知识。帕金森病患者入院和/或居住在住宅老年护理设施通常有多种并发症，使护理更加复杂。护理人员对帕金森病药物、其用途、副作用和给药方案以及安全护理实践的无知，可能会给患者造成不必要的痛苦和功能障碍。这两项试点研究采用了18个月的前/后测试/随访设计，在不同的时间范围内，采用研究小组和专家组编制的问卷对护士的自我评价进行评估，评估帕金森病的“感知”知识和实际知识，帕金森病药物和安全护理实践，以及对目标帕金森病教育计划的满意度。护士在医院试点（2006/8）显示赤字前测试的感知和实际的知识水平，这在后测试和后续显着增加。相比之下，在住宅老年护理试点（2008/10）的护士有较高的感知和实际（正确）的知识相关的经验，在预测试和这些水平在后续增加。两个试点研究队列对PDMPP作为帕金森病管理的教育和支持工具非常满意。这些研究结果与国际文献一致，国际文献指出，如果没有针对性的临床教育，护士不一定有足够的知识来有效管理帕金森病药物，并避免因延迟，错误和遗漏而产生的不必要的负面结果，他们也不知道如何为帕金森氏症患者提供安全有效的护理。一个完善的和资源丰富的帕金森病医学教育计划，如PDMPP，有可能改善临床实践中的缺陷。皇冠版权所有（C）2012由爱思唯尔有限公司出版。保留所有权利。
Aims: To determine the impact of a Parkinson's medicine education program on nurses' knowledge and practices in two settings where people with Parkinson's disease are cared for: hospitals and residential aged care facilities. The Parkinson's Disease Medication Protocol Program aimed to increase nurse knowledge of Parkinson's medication administration and safety in care management in order to improve health outcomes, function and wellbeing for the person with Parkinson's.Background: The ageing demographic of the developed world is concomitant with an increase in chronic disease, with Parkinson's disease being one of the most debilitating and costly. Individually complex medication regimens and unique spectrums of symptoms require disease-specific knowledge in nurses. People with Parkinson's disease admitted to hospitals and/or living in residential aged care facilities often have multiple co-morbidities, rendering care more complex still. Nurse ignorance of Parkinson's disease medicines, their uses, side effects and administration regimens, and safe care practices, can cause unnecessary distress and dysfunction for the person.Method: The two pilot studies employed an eighteen month pre/post-test/follow up design at different time frames, using a questionnaire developed by the study team and an expert panel to evaluate nurses' self-assessed 'perceived' knowledge and actual knowledge of Parkinson's disease, Parkinson's medicines and safe care practices, and satisfaction with the targeted Parkinson's education program.Results/findings: Nurses in the hospital pilot (2006/8) revealed deficits in pre-test perceived and actual knowledge levels, which increased significantly at post-test and follow-up. In contrast, in the residential aged care pilot (2008/10) the nurses had higher perceived and actual (correct) knowledge relevant to experience at pre-test and these levels increased at follow-up. Both pilot study cohorts were very satisfied with the PDMPP as an education and support vehicle in Parkinson's management.Conclusion: These study results concur with the international literature which identifies that without targeted clinical education nurses do not necessarily have sufficient knowledge to effectively manage Parkinson's medicines and avoid unnecessary negative outcomes arising from delays, errors and omissions, nor do they know how to provide safe and effective care for persons with Parkinson's. A well-developed and resourced Parkinson's medicine education program, such as the PDMPP, has the potential to improve deficits in clinical practice. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.